Neogen Corporation (NEOG) Social Stream



Neogen Corporation (NEOG): $18.51

-0.02 (-0.11%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add NEOG to Watchlist
Sign Up

NEOGEN CORP (NEOG) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NEOG.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-07-12 2 $25 $25 $25 $17.49 42.94%
2022-08-01 2 $26 $26 $26 $17.49 48.66%
2022-08-30 2 $20 $20 $20 $17.49 14.35%
2022-10-10 2 $14 $14 $14 $17.49 -19.95%
2022-12-14 2 $17 $17 $17 $17.49 -2.8%
2023-01-20 2 $20 $20 $20 $17.49 14.35%
2023-04-11 2 $19 $19 $19 $17.49 8.63%
NA 1 $NA $NA $NA $17.49 NA%

The Trend in the Analyst Price Target


Over the past 35 months, NEOG's average price target has gone down $58.5.

NEOG reports an average of 8.3% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-07-12 2 25 25 25 22.66 10.33%
2022-08-30 2 20 20 20 21.17 -5.53%
2022-10-10 2 14 14 14 12.11 15.61%
2023-04-10 2 19 19 19 17.30 9.83%
2023-04-11 2 19 19 19 17.54 8.32%

NEOG Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


NEOG's average broker recommendation rating improved by 1 over the prior 39 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how NEOGEN CORP fares relative to all US stocks, note that its number of analysts covering the stock is greater than 19.32% of that group.
  • To contextualize these metrics, consider that out of all US stocks, NEOGEN CORP's variance in analysts' estimates is lower than almost 100% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, NEOGEN CORP's upside potential (average analyst target price relative to current price) is higher than 93.1% of them.
  • NEOGEN CORP's average analyst price target is greater than 161.88% of stocks in the mid market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to NEOGEN CORP are EVO, ZNTL, and SDGR.

Is NEOG a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7315 seconds.